Physician profile

Andre Cole

Vascular Surgery · Vineland, NJ

NPI 1477902054

$40,235.49

in general payments reported to CMS, 2019-2025

28 companies · $25K in 2025

The $25K reported for 2025 was more than what 95% of Vascular Surgery providers received nationally (typical 2025 total: $927).

See the full distribution for Vascular Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$18,552.08
Consulting Fee$12,000.00
Food and Beverage$8,597.03

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Cagent Vascular INC $19,566.27 2025 Serrantor
Medtronic, INC. $5,496.35 2022-2025 Endurant Iis, Turbohawk, Anteralign Spinal System With Titan Nanolock Surface Technology
Abbott Laboratories $3,383.40 2023-2025 Supera, Esprit
Penumbra, INC. $1,892.20 2024-2025 Indigo System, Penumbra System, Ruby Coil
Philips North America LLC $1,351.05 2024 (Bh4) Igt Devices Undivided
Silk Road Medical, INC. $1,307.10 2023 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent
Stryker Corporation $1,265.17 2025 Clottriever Bold Catheter, Artix Mt, Ct Thrombectomy System Kit
Boston Scientific Corporation $1,129.30 2023-2025 Eluvia, Ranger, Ekosonic
Cook Medical LLC $1,094.23 2023-2025 Zenith Spiral-Z, Zenith, Zenith Alpha
Bard Peripheral Vascular, INC. $982.12 2023-2025 Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon, Distaflo Bypass Grafts
Inari Medical, INC. $744.96 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Cook Incorporated $427.20 2023 Zenith
Endologix LLC $326.96 2023-2025 Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System
Acera Surgical, INC. $315.33 2025 Restrata Wound Matrix
W. L. Gore & Associates, INC. $291.28 2023 Gore Excluder Iliac Branch Endoprosthesis, C3 Delivery System, Gore Tag Conformable Thoracic Endoprosthesis
Show all 28 companies
CompanyGeneral paymentsYearsTop products
Becton, Dickinson and Company $144.92 2024 Lutonix Drug Coated Balloon
Terumo Medical Corporation $120.37 2023 Metacross Otw, Glidesheath Slender, R2p Misago
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $82.95 2023 Lifevest
Shockwave Medical, INC $77.48 2022-2025
Lemaitre Vascular, INC. $40.17 2024-2025 Artegraft Vascular Graft, Anastoclip Gc 8cm (Medium)
Angiodynamics, INC. $30.06 2024 Auryon Laser System 100-120 Vac
Bolton Medical INC $29.85 2025 Treo Abdominal Stent-Graft System
Smith+Nephew, INC. $27.70 2025 Pico 14
Mozarc Medical US LLC $27.08 2024 Palindrome
Kci USA, INC. $23.37 2023 Prevena, V.A.C. Veraflo
Davol INC. $20.53 2024 Arista Ah Flexitip
Teleflex LLC $20.43 2024 Deknatel
Endo Pharmaceuticals INC. $17.66 2023 Nascobal

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Andre Cole

$40,235.49

in general payments reported 2019-2025

Years
2022-2025
Top company
Cagent Vascular INC
Context
The $25K reported for 2025 was more than what 95% of Vascular Surgery providers received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/11421203/andre-cole

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.